A cannabis capital raise
A cannabis raise runs on state licenses under a federal prohibition. Disclose the federal status plainly, document every license and the state rules on ownership changes, model taxes under section 280E, and check each investor against state suitability rules before access. Counsel review of the offering is not optional here.
Folder index
- 01 Overview Deck, states, license types, growth plan.
- 02 Risk disclosure PPM risk factors on federal status, tax, banking and enforcement.
- 03 Licenses State and local licenses by entity and site, with renewal dates.
- 04 Ownership rules State ownership change and investor suitability requirements.
- 05 Compliance Inspection reports, violations, track-and-trace compliance.
- 06 Tax Section 280E analysis, returns, tax positions taken.
- 07 Banking and cash Banking relationships, cash controls, payment processing.
How this raise works
As of this writing, marijuana remains listed in Schedule I of the federal Controlled Substances Act, even though many states license medical or adult-use sales. Federal rescheduling has been under consideration; check its current status when you draft risk factors. Hemp-derived products follow different rules. Investors are mostly specialist cannabis funds, family offices and individuals, because many institutions avoid the sector.
State law shapes the deal. Most states require approval or disclosure of new owners above a set stake, with background checks, so investors must be vetted before closing. Licenses, local permits and compliance history are core diligence items. While marijuana stays in Schedule I or II, section 280E of the Internal Revenue Code denies most deductions to businesses trafficking in it, which affects cash flow and valuation.
Securities law applies as usual: offerings rely on Reg D or another exemption, and the PPM must describe federal illegality, banking limits, tax and enforcement risks. Many cannabis businesses have limited access to banks, so investors look closely at cash handling and payment processing.
Best data rooms for this raise
The 16 rooms re-ranked with this raise's weights. Permission control carries the most weight here.
- Investor tracking 20%
- Permission control 27%
- Raise workflow 21%
- Investor onboarding 16%
- Cost of a raise 16%
-
Full deal room with AI, a listed price and a 14-day free trial.
Price $149 a month Trial 14-day free trial Features 8 of 12 listed -
Long-running M&A platform with layered permissions and fast support.
Price Priced on request Trial Free trial available Features 9 of 12 listed -
Bank-grade platform for large processes, with AI and a mobile app.
Price Priced on request Trial Demo on request Features 10 of 12 listed -
Deal room with AI and readiness tools for preparing a process.
Price Priced on request Trial Free trial available Features 8 of 12 listed -
One of the oldest deal rooms, common on bank-led transactions.
Price Priced on request Trial Demo on request Features 8 of 12 listed -
Easy, reliable deal room favored by mid-market advisers.
Price Priced on request Trial Free trial available Features 7 of 12 listed -
Simple flat-rate deal room with signing and Q&A.
Price $250 a month Trial Free trial available Features 8 of 12 listed -
Deal room with a listed monthly price and an open API.
Price $299 a month Trial Free trial available Features 7 of 12 listed -
Content cloud with watermarks and signing, priced per user.
Price $15 a user a month Trial Free trial available Features 9 of 12 listed -
European deal room strong in real estate, with AI features.
Price Priced on request Trial Demo on request Features 8 of 12 listed
Places 11 to 16: SmartRoom (7.0), DealRoom (7.0), ShareVault (6.8), Venue by DFIN (6.4), Digify (6.2), DocSend (5.8)
Folder index for the room
A starting index for this raise. Number the folders so the order survives exports and investors can cite them in questions.
- 01 OverviewDeck, states, license types, growth plan.
- 02 Risk disclosurePPM risk factors on federal status, tax, banking and enforcement.
- 03 LicensesState and local licenses by entity and site, with renewal dates.
- 04 Ownership rulesState ownership change and investor suitability requirements.
- 05 ComplianceInspection reports, violations, track-and-trace compliance.
- 06 TaxSection 280E analysis, returns, tax positions taken.
- 07 Banking and cashBanking relationships, cash controls, payment processing.
- 08 Real estateLeases and zoning approvals for each site.
- 09 Corporate structureEntity chart, management agreements, cap table.
- 10 FinancialsStatements, model, debt.
Features this raise needs
| Feature | Why | Ellty | iDeals | Datasite | Ansarada | Intralinks | Firmex |
|---|---|---|---|---|---|---|---|
| Investor activity log | A per-investor record of opens, pages and minutes, which tells the IR team who is in diligence and who stalled. | ||||||
| View-only files | Files can be read but not saved or printed, and the setting can change mid-raise without a new invite. | ||||||
| Dynamic watermarks | Stamps the reader and a timestamp over every page, so a PPM that leaks carries its source with it. | ||||||
| 2-step verification | A code or an approval on a second device every time someone logs in. | ||||||
| NDA e-sign step | Confidentiality terms an investor must accept in the room before folder one appears. |
Setting up the room
- 01
Draft the risk factors first
Have counsel write the federal status, tax and banking disclosures before marketing starts.
- 02
Vet investors
Check each investor against state ownership and background rules before granting deep access.
- 03
Index every license
List licenses by entity, site and renewal date, with any conditions attached.
- 04
Model 280E
Show after-tax cash flow with the 280E limits, not pre-tax figures alone.
- 05
Log access closely
Keep a full record of who opened what, given regulatory scrutiny.
Common mistakes
- Risk factors that understate the federal legal position.
- Admitting an investor who later fails a state suitability review.
- Valuations based on pre-tax earnings that ignore 280E.
- A license held by an entity outside the corporate structure being sold.
Calculators for this raise
Or take the four-question quiz and check the raise checklist.
Questions and answers
Is cannabis legal under federal law?
As of this writing marijuana is listed in Schedule I of the Controlled Substances Act. Rescheduling has been under consideration, so check the current status before you raise.
Can a cannabis company use Reg D?
Yes, cannabis businesses raise under securities exemptions such as Reg D, with full disclosure of federal and state risks.
What is section 280E?
A tax rule that denies most deductions and credits to businesses trafficking in Schedule I or II controlled substances, raising effective tax rates for marijuana businesses.